MOWOOT SIGNED
Integral Intestinal Transit Management System for chronic constipation
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0MOWOOT project word cloud
Explore the words cloud of the MOWOOT project. It provides you a very rough idea of what is the project "MOWOOT" about.
Project "MOWOOT" data sheet
The following table provides information about the project.
| Coordinator |
USMIMA SL
Organization address contact info |
| Coordinator Country | Spain [ES] |
| Project website | https://www.mowoot.com/en/ |
| Total cost | 1˙632˙148 € |
| EC max contribution | 1˙142˙504 € (70%) |
| Programme |
1. H2020-EU.3.1.4. (Active ageing and self-management of health) 2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.1.6. (Health care provision and integrated care) |
| Code Call | H2020-SMEINST-2-2016-2017 |
| Funding Scheme | SME-2 |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-04-01 to 2019-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | USMIMA SL | ES (CERVELLO BARCELONA) | coordinator | 1˙142˙504.00 |
Map
Project objective
Up to 15% of the EU and USA population suffer from Chronic Constipation. The most affected collectives are women, aging people and patients with Neurogenic Bowel disorders related to Spinal cord injury, Parkinson and Multiple Sclerosis. Constipation causes a painful evacuation, faecal impaction and faecal incontinence, which have a big negative impact on the quality of life of these patients.
USMIMA S.L., created in 2014, offers MOWOOT, a non-pharmacological, non-invasive solution to relieve chronical constipation, without side-effects, in form of a wearable class II medical device that automatically emulates the abdominal massage techniques of professional therapists via a number of actuators. A pilot study with chronically constipated patients has already shown that the daily use of MOWOOT ameliorates idiopathic chronic constipation (TRL7).
USMIMA wants to target a 90B M€ market of 150 million people with chronic constipation identified. A feasibility study showed that, in order to target this market and increase the influence on target clients, USMIMA has to priorize the following activities during this phase 2:
• Conduct a larger clinical study as a marketing strategy to build confidence in the medical sector and promote MOWOOT prescriptions • Upgrade Mowoot 1.0 prototype to Mowoot 2.0 product, by adding cloud and smart services and other features required by users • Reduce costs (below current 500€) through scaling the manufacturing process
MOWOOT is expected to produce a big impact on USMIMA by: • Generating 2.5 M€ of EBITDA by 2018 • Incorporating 5 new specialized employees to complement current staff profiles • Introducing MOWOOT products in EU and USA markets by 2019
Moreover, MOWOOT will empower patients and elderly people, enhance well-being among the society, increase autonomy and reduce the increasing health care expenses due to aging population and the derived long-term cares.
Deliverables
| Certification report: AEMPS, ISO 13485, CE | Documents, reports | 2020-03-11 14:37:13 |
| Mowoot 2.0 prototype (50-100 u) | Demonstrators, pilots, prototypes | 2020-01-21 15:58:03 |
| Study Material (informed consent, evacuation diaries…) | Documents, reports | 2020-01-21 15:58:03 |
| IRB’s and Competent Authorities approval | Documents, reports | 2020-01-21 15:58:03 |
| Midterm Mowoot 2.0 prototype (2-4 u) | Demonstrators, pilots, prototypes | 2020-01-21 15:58:03 |
Take a look to the deliverables list in detail: detailed list of MOWOOT deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2019 |
C.Jané, G.Romero-Culleres, N.Ticó, I.Alonso, I.Herrero-Fresneda \'Efectividad de la exo-peristalsis Intermitente de Colon con Mowoot como Tratamiento del Estreñimiento Crónico published pages: , ISSN: , DOI: |
IV Congreso Internacional de Fisioterapia en PelviperineologÃa de la Sociedad Española de Fisioterapia en PelviperineologÃa (SEFIP) | 2020-01-28 |
| 2018 |
I. Herrero-Fresneda, J. Klamburg, M. Benet, A. Calzada, M. Wilhelms BENEFITS OF AUTOMATIC MASSAGE WITH MOWOOT ON CHRONIC CONSTIPATION published pages: 46-47, ISSN: 2161-069X, DOI: |
Journal of Gastrointestinal & Digestive System | 2020-01-21 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOWOOT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MOWOOT" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)
CLINICOVERY (2018)
CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research
Read MoreJUMPAIR (2018)
Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers
Read MoreClearRing (2018)
An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.
Read More